The prevalence of gram-negative bacteria with difficult-to-treat resistance and utilization of novel β-lactam antibiotics in the southeastern United States.
Y Vivian TsaiPaul Brandon BookstaverJoseph KohnJulie Ann JustoDarrell T ChildressStefanie Anne StramelDouglas SlainPatrick J TuMary Joyce B WinglerBruce M JonesDaniel T AndersonMegan M SeddonDavid A CretellaJoshua EudyHana Rac WindersKayla AntoszPamela L BaileyMajdi N Al-HasanPublished in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2024)
The overall prevalence of GNB with DTR and the use of novel β-lactams remain low. However, the uptrend in the use of novel β-lactams after adjusting for microbiological burden suggests a higher utilization relative to the prevalence of GNB with DTR.